| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |